🇺🇸 FDA
Pipeline program

Bempedoic Acid / Ezetimibe Oral Tablet

1824539

Approved small_molecule active

Quick answer

Bempedoic Acid / Ezetimibe Oral Tablet for Cardiovascular Diseases is a Approved program (small_molecule) at Esperion Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Esperion Therapeutics
Indication
Cardiovascular Diseases
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials